학술논문

Liraglutide as add-on to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes: a 26-week, randomised, double-blind, placebo-controlled trial
Document Type
Journal
Source
DIABETOLOGIA; SEP 2019, 62 pS371-pS372, 2p. Supplement: 1
Subject
Language
English
ISSN
14320428